In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cenomed BioSciences LLC

Division of Celgene Corp.

Latest From Cenomed BioSciences LLC

Epiomed Therapeutics Inc.

The various triggers that case nausea and vomiting are conveyed to the brain via different pathways that converge to create a final common pathway leading to the vomiting center in the medulla region of the brain. Previous attempts to develop drugs that target this common pathway have failed in the clinic because they produced anxiety and panic attacks, but Epiomed Therapeutics Inc. thinks it has discovered the reasons for the anxiety and is developing a redesigned product devoid of this side effect.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Cenomed Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Celgene Corp.
  • Senior Management
  • David R Helton, Pres., CEO, & CSO
    Joseph Tizzano, PhD, VP, R&D
  • Contact Info
  • Cenomed BioSciences LLC
    Phone: (949) 838-0344
    43 Corporate Park
    Ste. 103
    Irvine, CA 92606-5137